Erythromycin B rearranged derivatives CAS CATO-C4X-100170

Description

Compared with other compounds in its class, the molecular weight of 714.93 g/mol gives Erythromycin B rearranged derivatives distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

Erythromycin B rearranged derivatives (CAS CATO-C4X-100170), molecular formula C37H66N2O11 and molecular weight 714.93 g/mol, is a CATO reference standard with documented purity and traceability.

Based on its molecular formula C37H66N2O11, Erythromycin B rearranged derivatives contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 714.93 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.

CATO manufactures Erythromycin B rearranged derivatives under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com